| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | bile acid binding | 7.26e-07 | 10 | 156 | 4 | GO:0032052 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 1.86e-06 | 4 | 156 | 3 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 1.86e-06 | 4 | 156 | 3 | GO:0045703 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 1.86e-06 | 4 | 156 | 3 | GO:0047743 | |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 4.62e-06 | 5 | 156 | 3 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 4.62e-06 | 5 | 156 | 3 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 4.62e-06 | 5 | 156 | 3 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 4.62e-06 | 5 | 156 | 3 | GO:0047006 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 4.62e-06 | 5 | 156 | 3 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 4.62e-06 | 5 | 156 | 3 | GO:0047086 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 4.62e-06 | 5 | 156 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 4.62e-06 | 5 | 156 | 3 | GO:0047787 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 9.20e-06 | 6 | 156 | 3 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 1.60e-05 | 7 | 156 | 3 | GO:0072582 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 2.55e-05 | 8 | 156 | 3 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 2.55e-05 | 8 | 156 | 3 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 2.55e-05 | 8 | 156 | 3 | GO:0035671 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 3.80e-05 | 9 | 156 | 3 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 3.80e-05 | 9 | 156 | 3 | GO:0070401 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 5.39e-05 | 10 | 156 | 3 | GO:0047045 | |
| GeneOntologyMolecularFunction | pyruvate kinase activity | 6.06e-05 | 2 | 156 | 2 | GO:0004743 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | EPHB3 SMG1 TSSK6 NPR1 ABL1 CAMK2A CLK4 INSRR HUNK ARAF RNASEL PKLR PKM SRPK3 COASY PLK3 | 1.41e-04 | 709 | 156 | 16 | GO:0016773 |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 1.60e-04 | 14 | 156 | 3 | GO:0004032 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 1.60e-04 | 14 | 156 | 3 | GO:0001758 | |
| GeneOntologyMolecularFunction | N-acylphosphatidylethanolamine-specific phospholipase D activity | 1.81e-04 | 3 | 156 | 2 | GO:0070290 | |
| GeneOntologyMolecularFunction | protein kinase activity | EPHB3 SMG1 TSSK6 NPR1 ABL1 CAMK2A CLK4 INSRR HUNK ARAF RNASEL PKM SRPK3 PLK3 | 2.67e-04 | 600 | 156 | 14 | GO:0004672 |
| GeneOntologyMolecularFunction | kinase activity | EPHB3 SMG1 TSSK6 NPR1 ABL1 CAMK2A CLK4 INSRR HUNK ARAF RNASEL PKLR PKM SRPK3 COASY PLK3 | 3.27e-04 | 764 | 156 | 16 | GO:0016301 |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 3.60e-04 | 4 | 156 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 4.84e-04 | 20 | 156 | 3 | GO:0004303 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 8.39e-04 | 24 | 156 | 3 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 1.07e-03 | 26 | 156 | 3 | GO:0004022 | |
| GeneOntologyMolecularFunction | NADPH binding | 1.07e-03 | 26 | 156 | 3 | GO:0070402 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 1.19e-03 | 27 | 156 | 3 | GO:0008106 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 1.53e-03 | 107 | 156 | 5 | GO:0033293 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 1.63e-03 | 30 | 156 | 3 | GO:0018455 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 1.96e-03 | 32 | 156 | 3 | GO:0004033 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 2.15e-03 | 33 | 156 | 3 | GO:0033764 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 2.34e-03 | 34 | 156 | 3 | GO:0016628 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 2.78e-03 | 239 | 156 | 7 | GO:0031406 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | EPHB3 SMG1 TSSK6 NPR1 ABL1 CAMK2A CLK4 INSRR HUNK ARAF RNASEL PKLR PKM SRPK3 COASY PLK3 | 2.79e-03 | 938 | 156 | 16 | GO:0016772 |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 3.18e-03 | 11 | 156 | 2 | GO:0030283 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 3.48e-03 | 39 | 156 | 3 | GO:0016229 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 3.74e-03 | 40 | 156 | 3 | GO:0016709 | |
| GeneOntologyMolecularFunction | dystroglycan binding | 3.80e-03 | 12 | 156 | 2 | GO:0002162 | |
| GeneOntologyMolecularFunction | organic acid binding | 3.88e-03 | 254 | 156 | 7 | GO:0043177 | |
| GeneOntologyMolecularFunction | protein phosphatase 2A binding | 4.30e-03 | 42 | 156 | 3 | GO:0051721 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 1.59e-06 | 4 | 153 | 3 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 1.59e-06 | 4 | 153 | 3 | GO:0006709 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 1.59e-06 | 4 | 153 | 3 | GO:0071395 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 1.59e-06 | 4 | 153 | 3 | GO:0008208 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 3.96e-06 | 5 | 153 | 3 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 3.96e-06 | 5 | 153 | 3 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 3.96e-06 | 5 | 153 | 3 | GO:0045827 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 3.96e-06 | 5 | 153 | 3 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 3.96e-06 | 5 | 153 | 3 | GO:0120256 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 3.96e-06 | 5 | 153 | 3 | GO:1900053 | |
| GeneOntologyBiologicalProcess | response to prostaglandin | 6.59e-06 | 36 | 153 | 5 | GO:0034694 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 7.87e-06 | 6 | 153 | 3 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 7.87e-06 | 6 | 153 | 3 | GO:0016095 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 1.37e-05 | 7 | 153 | 3 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 1.37e-05 | 7 | 153 | 3 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 1.37e-05 | 7 | 153 | 3 | GO:1900052 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 2.31e-05 | 23 | 153 | 4 | GO:0071379 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 3.25e-05 | 9 | 153 | 3 | GO:0044597 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 4.62e-05 | 10 | 153 | 3 | GO:0044598 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 4.62e-05 | 10 | 153 | 3 | GO:0019747 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 4.62e-05 | 10 | 153 | 3 | GO:0046137 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 4.62e-05 | 10 | 153 | 3 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 4.62e-05 | 10 | 153 | 3 | GO:0030647 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 6.32e-05 | 11 | 153 | 3 | GO:2000224 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 6.32e-05 | 11 | 153 | 3 | GO:0016115 | |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 1.37e-04 | 14 | 153 | 3 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 1.37e-04 | 14 | 153 | 3 | GO:0008300 | |
| GeneOntologyBiologicalProcess | diterpenoid biosynthetic process | 1.71e-04 | 15 | 153 | 3 | GO:0016102 | |
| GeneOntologyBiologicalProcess | testosterone biosynthetic process | 2.09e-04 | 16 | 153 | 3 | GO:0061370 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 2.09e-04 | 16 | 153 | 3 | GO:0032351 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 2.16e-04 | 40 | 153 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 3.01e-04 | 18 | 153 | 3 | GO:0030656 | |
| GeneOntologyBiologicalProcess | DN4 thymocyte differentiation | 3.25e-04 | 4 | 153 | 2 | GO:1904157 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 4.83e-04 | 21 | 153 | 3 | GO:0042447 | |
| GeneOntologyBiologicalProcess | terpenoid biosynthetic process | 4.83e-04 | 21 | 153 | 3 | GO:0016114 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid receptor signaling pathway | 4.83e-04 | 21 | 153 | 3 | GO:0048385 | |
| GeneOntologyBiologicalProcess | retinal metabolic process | 4.83e-04 | 21 | 153 | 3 | GO:0042574 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 4.83e-04 | 21 | 153 | 3 | GO:0042182 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 5.29e-04 | 89 | 153 | 5 | GO:0001523 | |
| GeneOntologyBiologicalProcess | parturition | 5.56e-04 | 22 | 153 | 3 | GO:0007567 | |
| GeneOntologyBiologicalProcess | glycoside metabolic process | 5.56e-04 | 22 | 153 | 3 | GO:0016137 | |
| GeneOntologyBiologicalProcess | progesterone metabolic process | 5.56e-04 | 22 | 153 | 3 | GO:0042448 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 5.56e-04 | 22 | 153 | 3 | GO:1902644 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 6.36e-04 | 23 | 153 | 3 | GO:0034310 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 6.79e-04 | 94 | 153 | 5 | GO:0016101 | |
| GeneOntologyBiologicalProcess | pyruvate biosynthetic process | 8.04e-04 | 6 | 153 | 2 | GO:0042866 | |
| GeneOntologyBiologicalProcess | regulation of ketone biosynthetic process | 9.18e-04 | 26 | 153 | 3 | GO:0010566 | |
| GeneOntologyCellularComponent | pyruvate kinase complex | 5.61e-05 | 2 | 157 | 2 | GO:1902912 | |
| GeneOntologyCellularComponent | ciliary pocket membrane | 1.67e-04 | 3 | 157 | 2 | GO:0020018 | |
| GeneOntologyCellularComponent | ciliary pocket | 1.67e-04 | 3 | 157 | 2 | GO:0020016 | |
| MousePheno | increased oligodendrocyte number | 2.93e-06 | 13 | 115 | 4 | MP:0010160 | |
| MousePheno | long gestation period | 5.53e-06 | 15 | 115 | 4 | MP:0002293 | |
| MousePheno | abnormal gestational length | 1.22e-05 | 18 | 115 | 4 | MP:0002292 | |
| MousePheno | parturition failure | 6.24e-05 | 10 | 115 | 3 | MP:0012010 | |
| MousePheno | hypermyelination | 8.53e-05 | 11 | 115 | 3 | MP:0010050 | |
| Domain | Znf_C2H2-like | ZNF609 ZNF607 ADNP2 ZBTB41 CPXCR1 ZNF365 ZNF768 ZNF441 RLF ZBTB39 ZNF780A DPF3 ZNF655 ZNF335 ZNF197 ZNF69 ZNF528 ZNF415 ZNF222 ZNF574 | 9.92e-06 | 796 | 155 | 20 | IPR015880 |
| Domain | Znf_C2H2 | ZNF609 ZNF607 ADNP2 ZBTB41 CPXCR1 ZNF365 ZNF768 ZNF441 RLF ZBTB39 ZNF780A DPF3 ZNF655 ZNF335 ZNF197 ZNF69 ZNF528 ZNF415 ZNF222 ZNF574 | 1.17e-05 | 805 | 155 | 20 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF609 ZNF607 ADNP2 ZBTB41 CPXCR1 ZNF365 ZNF768 ZNF441 RLF ZBTB39 ZNF780A DPF3 ZNF655 ZNF335 ZNF197 ZNF69 ZNF528 ZNF415 ZNF222 ZNF574 | 1.23e-05 | 808 | 155 | 20 | SM00355 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF609 ZNF607 ADNP2 ZBTB41 CPXCR1 ZNF768 ZNF441 RLF ZBTB39 ZNF780A DPF3 ZNF655 ZNF335 ZNF197 ZNF69 ZNF528 ZNF415 ZNF222 ZNF574 | 2.36e-05 | 775 | 155 | 19 | PS50157 |
| Domain | ALDOKETO_REDUCTASE_1 | 6.45e-05 | 10 | 155 | 3 | PS00798 | |
| Domain | ALDOKETO_REDUCTASE_2 | 6.45e-05 | 10 | 155 | 3 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 6.45e-05 | 10 | 155 | 3 | PS00063 | |
| Domain | Aldo/ket_reductase_CS | 6.45e-05 | 10 | 155 | 3 | IPR018170 | |
| Domain | Aldo/keto_reductase | 6.45e-05 | 10 | 155 | 3 | IPR020471 | |
| Domain | - | 6.84e-05 | 2 | 155 | 2 | 3.40.1380.20 | |
| Domain | PYRUVATE_KINASE | 6.84e-05 | 2 | 155 | 2 | PS00110 | |
| Domain | Pyrv_Knase_insert_dom | 6.84e-05 | 2 | 155 | 2 | IPR015806 | |
| Domain | PK | 6.84e-05 | 2 | 155 | 2 | PF00224 | |
| Domain | PK_C | 6.84e-05 | 2 | 155 | 2 | PF02887 | |
| Domain | - | 6.84e-05 | 2 | 155 | 2 | 2.40.33.10 | |
| Domain | Pyrv_Knase_AS | 6.84e-05 | 2 | 155 | 2 | IPR018209 | |
| Domain | Pyrv_Knase_brl | 6.84e-05 | 2 | 155 | 2 | IPR015793 | |
| Domain | Pyrv_Knase_a/b | 6.84e-05 | 2 | 155 | 2 | IPR015794 | |
| Domain | Pyrv_Knase_C | 6.84e-05 | 2 | 155 | 2 | IPR015795 | |
| Domain | EHD1/EHD3 | 6.84e-05 | 2 | 155 | 2 | IPR029951 | |
| Domain | TPR_REGION | 7.17e-05 | 165 | 155 | 8 | PS50293 | |
| Domain | TPR | 7.17e-05 | 165 | 155 | 8 | PS50005 | |
| Domain | ZINC_FINGER_C2H2_1 | ZNF609 ZNF607 ADNP2 ZBTB41 ZNF768 ZNF441 RLF ZBTB39 ZNF780A DPF3 ZNF655 ZNF335 ZNF197 ZNF69 ZNF528 ZNF415 ZNF222 ZNF574 | 8.14e-05 | 777 | 155 | 18 | PS00028 |
| Domain | - | ZNF607 ZBTB41 ZNF768 ZNF441 RLF ZBTB39 ZNF780A DPF3 ZNF655 ZNF335 ZNF197 ZNF69 ZNF528 ZNF415 ZNF222 ZNF574 | 1.70e-04 | 679 | 155 | 16 | 3.30.160.60 |
| Domain | Kinase-like_dom | EPHB3 SMG1 TSSK6 NPR1 ABL1 CAMK2A CLK4 INSRR HUNK ARAF RNASEL SRPK3 DMD PLK3 | 1.74e-04 | 542 | 155 | 14 | IPR011009 |
| Domain | Pyr_Knase | 2.04e-04 | 3 | 155 | 2 | IPR001697 | |
| Domain | Pyrv/PenolPyrv_Kinase-like_dom | 2.04e-04 | 3 | 155 | 2 | IPR015813 | |
| Domain | - | 2.04e-04 | 3 | 155 | 2 | 3.20.20.60 | |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF607 ZBTB41 ZNF768 ZNF441 RLF ZBTB39 ZNF780A DPF3 ZNF655 ZNF335 ZNF197 ZNF69 ZNF528 ZNF415 ZNF222 ZNF574 | 2.18e-04 | 694 | 155 | 16 | IPR013087 |
| Domain | - | 2.90e-04 | 16 | 155 | 3 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 3.50e-04 | 17 | 155 | 3 | IPR023210 | |
| Domain | Aldo_ket_red | 3.50e-04 | 17 | 155 | 3 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 3.50e-04 | 17 | 155 | 3 | IPR001395 | |
| Domain | - | 4.06e-04 | 4 | 155 | 2 | 2.40.30.110 | |
| Domain | PID_Shc-like | 4.06e-04 | 4 | 155 | 2 | IPR006019 | |
| Domain | GcvT/YgfZ_C | 4.06e-04 | 4 | 155 | 2 | IPR029043 | |
| Domain | zf-C2H2 | ZNF607 ZBTB41 ZNF768 ZNF441 RLF ZBTB39 ZNF780A ZNF655 ZNF335 ZNF197 ZNF69 ZNF528 ZNF415 ZNF222 ZNF574 | 6.65e-04 | 693 | 155 | 15 | PF00096 |
| Domain | GCV_T | 6.73e-04 | 5 | 155 | 2 | PF01571 | |
| Domain | EHD_N | 6.73e-04 | 5 | 155 | 2 | IPR031692 | |
| Domain | - | 6.73e-04 | 5 | 155 | 2 | 3.30.1360.120 | |
| Domain | TrmE/GcvT_dom1 | 6.73e-04 | 5 | 155 | 2 | IPR027266 | |
| Domain | Pyrv_Knase-like_insert_dom | 6.73e-04 | 5 | 155 | 2 | IPR011037 | |
| Domain | GCV_T_C | 6.73e-04 | 5 | 155 | 2 | IPR013977 | |
| Domain | GCV_T_C | 6.73e-04 | 5 | 155 | 2 | PF08669 | |
| Domain | GCV_T_N | 6.73e-04 | 5 | 155 | 2 | IPR006222 | |
| Domain | EHD_N | 6.73e-04 | 5 | 155 | 2 | PF16880 | |
| Domain | TPR-like_helical_dom | 7.43e-04 | 233 | 155 | 8 | IPR011990 | |
| Domain | CUB | 7.81e-04 | 50 | 155 | 4 | SM00042 | |
| Domain | Prot_kinase_dom | EPHB3 TSSK6 NPR1 ABL1 CAMK2A CLK4 INSRR HUNK ARAF RNASEL SRPK3 PLK3 | 7.99e-04 | 489 | 155 | 12 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | EPHB3 TSSK6 NPR1 ABL1 CAMK2A CLK4 INSRR HUNK ARAF RNASEL SRPK3 PLK3 | 8.57e-04 | 493 | 155 | 12 | PS50011 |
| Domain | - | 9.06e-04 | 52 | 155 | 4 | 2.60.120.290 | |
| Domain | CUB | 9.74e-04 | 53 | 155 | 4 | PS01180 | |
| Domain | - | 1.11e-03 | 248 | 155 | 8 | 1.25.40.20 | |
| Domain | ANK | 1.20e-03 | 251 | 155 | 8 | SM00248 | |
| Domain | ANK_REPEAT | 1.26e-03 | 253 | 155 | 8 | PS50088 | |
| Domain | Protein_kinase_ATP_BS | 1.28e-03 | 379 | 155 | 10 | IPR017441 | |
| Domain | CUB_dom | 1.28e-03 | 57 | 155 | 4 | IPR000859 | |
| Domain | Ankyrin_rpt-contain_dom | 1.29e-03 | 254 | 155 | 8 | IPR020683 | |
| Domain | ANK_REP_REGION | 1.29e-03 | 254 | 155 | 8 | PS50297 | |
| Domain | Ankyrin_rpt | 1.58e-03 | 262 | 155 | 8 | IPR002110 | |
| Domain | TPR-contain_dom | 1.59e-03 | 150 | 155 | 6 | IPR013026 | |
| Domain | PROTEIN_KINASE_ATP | EPHB3 TSSK6 ABL1 CAMK2A CLK4 INSRR HUNK ARAF RNASEL SRPK3 PLK3 | 1.59e-03 | 459 | 155 | 11 | PS00107 |
| Domain | - | 1.73e-03 | 207 | 155 | 7 | 1.25.40.10 | |
| Domain | Sialidases | 2.37e-03 | 9 | 155 | 2 | IPR011040 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 2.60e-03 | 69 | 155 | 4 | IPR020636 | |
| Domain | EF-hand_4 | 2.95e-03 | 10 | 155 | 2 | PF12763 | |
| Pathway | REACTOME_PREDNISONE_ADME | 3.08e-05 | 23 | 113 | 4 | MM16639 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 4.07e-05 | 9 | 113 | 3 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 4.07e-05 | 9 | 113 | 3 | M47817 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 7.90e-05 | 11 | 113 | 3 | M47812 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 1.35e-04 | 13 | 113 | 3 | M17842 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 1.35e-04 | 13 | 113 | 3 | MM14747 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 1.71e-04 | 14 | 113 | 3 | M46449 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 1.71e-04 | 14 | 113 | 3 | M27074 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 1.71e-04 | 14 | 113 | 3 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 1.71e-04 | 14 | 113 | 3 | MM14748 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 2.13e-04 | 15 | 113 | 3 | MM14870 | |
| Pubmed | 9.20e-08 | 3 | 158 | 3 | 19320734 | ||
| Pubmed | 9.20e-08 | 3 | 158 | 3 | 12906867 | ||
| Pubmed | Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. | 9.20e-08 | 3 | 158 | 3 | 31780644 | |
| Pubmed | 9.20e-08 | 3 | 158 | 3 | 13678667 | ||
| Pubmed | 9.20e-08 | 3 | 158 | 3 | 21232532 | ||
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 3.67e-07 | 4 | 158 | 3 | 10500239 | |
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 3.67e-07 | 4 | 158 | 3 | 14967952 | |
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 10393440 | ||
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 3.67e-07 | 4 | 158 | 3 | 15193432 | |
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 3.67e-07 | 4 | 158 | 3 | 31479646 | |
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 16191478 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 15577209 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 10702227 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 17034817 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 3.67e-07 | 4 | 158 | 3 | 29764944 | |
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 17888864 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 17442338 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 28329705 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 19237748 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 28259989 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 16511129 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 7789999 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 20124700 | ||
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 3.67e-07 | 4 | 158 | 3 | 16508162 | |
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 15222881 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 17629694 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 10526179 | ||
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 3.67e-07 | 4 | 158 | 3 | 19091768 | |
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 16018803 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 17272929 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 3.67e-07 | 4 | 158 | 3 | 18667791 | |
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 21521174 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 8274401 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 3.67e-07 | 4 | 158 | 3 | 34590152 | |
| Pubmed | RELN ATP13A1 CAMK2A PEG10 ASH1L ADNP2 AIP HUNK ZNF365 SLC4A3 TXNDC11 NELL2 CELSR3 SATB1 ZNF655 ZNF197 PKM AKR1C3 GPSM2 ZNF528 DNAI7 | 4.14e-07 | 1285 | 158 | 21 | 35914814 | |
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 9.14e-07 | 5 | 158 | 3 | 21851338 | |
| Pubmed | 9.14e-07 | 5 | 158 | 3 | 15212687 | ||
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 9.14e-07 | 5 | 158 | 3 | 16984997 | |
| Pubmed | 9.14e-07 | 5 | 158 | 3 | 7737980 | ||
| Pubmed | 9.14e-07 | 5 | 158 | 3 | 17872381 | ||
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 9.14e-07 | 5 | 158 | 3 | 17064890 | |
| Pubmed | 9.14e-07 | 5 | 158 | 3 | 10672042 | ||
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 9.14e-07 | 5 | 158 | 3 | 17855024 | |
| Pubmed | 9.14e-07 | 5 | 158 | 3 | 38788959 | ||
| Pubmed | 9.14e-07 | 5 | 158 | 3 | 18003893 | ||
| Pubmed | 1.82e-06 | 6 | 158 | 3 | 19273550 | ||
| Pubmed | 1.82e-06 | 6 | 158 | 3 | 15471942 | ||
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 1.82e-06 | 6 | 158 | 3 | 26748576 | |
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 1.82e-06 | 6 | 158 | 3 | 29107092 | |
| Pubmed | 1.82e-06 | 6 | 158 | 3 | 15860270 | ||
| Pubmed | 1.82e-06 | 6 | 158 | 3 | 17122075 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 1.82e-06 | 6 | 158 | 3 | 17255200 | |
| Pubmed | 3.18e-06 | 7 | 158 | 3 | 22529366 | ||
| Pubmed | 3.18e-06 | 7 | 158 | 3 | 33127481 | ||
| Pubmed | 3.18e-06 | 7 | 158 | 3 | 12562828 | ||
| Pubmed | 3.18e-06 | 7 | 158 | 3 | 26160177 | ||
| Pubmed | Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. | 3.18e-06 | 7 | 158 | 3 | 34843575 | |
| Pubmed | 3.18e-06 | 7 | 158 | 3 | 19846565 | ||
| Pubmed | 3.18e-06 | 7 | 158 | 3 | 16337335 | ||
| Pubmed | 5.07e-06 | 8 | 158 | 3 | 12475935 | ||
| Pubmed | 5.07e-06 | 8 | 158 | 3 | 33584538 | ||
| Pubmed | 5.07e-06 | 8 | 158 | 3 | 9224647 | ||
| Pubmed | 5.07e-06 | 8 | 158 | 3 | 20837989 | ||
| Pubmed | 7.57e-06 | 9 | 158 | 3 | 31491533 | ||
| Pubmed | 7.57e-06 | 9 | 158 | 3 | 33348080 | ||
| Pubmed | A2M SMG1 ZNF609 TCF12 ORC3 MIB2 ERGIC2 ARAF CEMIP MARF1 AKAP13 CHPF2 ZNF574 | 9.38e-06 | 650 | 158 | 13 | 38777146 | |
| Pubmed | Lack of placental neurosteroid alters cortical development and female somatosensory function. | 1.08e-05 | 10 | 158 | 3 | 36313771 | |
| Pubmed | IFT140 ZNF609 TCF12 ASH1L ADNP2 ZNF768 ARAF NCOR2 NELL2 SMG7 DPF3 EPC1 CHPF2 CEP295 PLD1 CSMD1 ZNF574 | 1.41e-05 | 1116 | 158 | 17 | 31753913 | |
| Pubmed | 1.96e-05 | 12 | 158 | 3 | 25774556 | ||
| Pubmed | Endogenous biotin as a marker of adrenocortical cells with steroidogenic potential. | 1.96e-05 | 12 | 158 | 3 | 21256921 | |
| Pubmed | Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1. | 1.96e-05 | 12 | 158 | 3 | 28893949 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 8573067 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 11960989 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 15492289 | ||
| Pubmed | Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. | 2.05e-05 | 2 | 158 | 2 | 15996096 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 28743549 | ||
| Pubmed | SUMOylation of EHD3 Modulates Tubulation of the Endocytic Recycling Compartment. | 2.05e-05 | 2 | 158 | 2 | 26226295 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 30367463 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 21217827 | ||
| Pubmed | Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients. | 2.05e-05 | 2 | 158 | 2 | 24408017 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 8486699 | ||
| Pubmed | Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. | 2.05e-05 | 2 | 158 | 2 | 16510495 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 11514561 | ||
| Pubmed | Phospholipase D1 facilitates second-phase myoblast fusion and skeletal muscle regeneration. | 2.05e-05 | 2 | 158 | 2 | 25428992 | |
| Pubmed | Local androgen inactivation in abdominal visceral adipose tissue. | 2.05e-05 | 2 | 158 | 2 | 14671194 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 17389905 | ||
| Pubmed | AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer. | 2.05e-05 | 2 | 158 | 2 | 16338060 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 23165153 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 33675863 | ||
| Pubmed | Unique proline-rich domain regulates the chaperone function of AIPL1. | 2.05e-05 | 2 | 158 | 2 | 23418749 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 34830394 | ||
| Pubmed | cDNA and deduced amino acid sequences of a human colon dihydrodiol dehydrogenase. | 2.05e-05 | 2 | 158 | 2 | 8011662 | |
| Pubmed | A genetic association study of CSMD1 and CSMD2 with cognitive function. | 2.05e-05 | 2 | 158 | 2 | 27890662 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 18654764 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 15135664 | ||
| Pubmed | The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. | 2.05e-05 | 2 | 158 | 2 | 21439553 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 26934124 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 27333658 | ||
| Interaction | POTED interactions | 1.71e-06 | 4 | 153 | 3 | int:POTED | |
| Cytoband | 10p15-p14 | 7.94e-07 | 6 | 158 | 3 | 10p15-p14 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF609 ZNF607 ADNP2 ZBTB41 ZNF365 ZNF768 ZNF441 RLF ZBTB39 ZNF780A ZNF655 ZNF335 ZNF197 ZNF69 ZNF528 ZNF415 ZNF222 ZNF574 | 1.13e-07 | 718 | 103 | 18 | 28 |
| GeneFamily | Aldo-keto reductases | 7.77e-05 | 15 | 103 | 3 | 399 | |
| GeneFamily | Ankyrin repeat domain containing | 4.70e-04 | 242 | 103 | 7 | 403 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 2.41e-03 | 13 | 103 | 2 | 685 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.78e-03 | 181 | 103 | 5 | 694 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 4.20e-03 | 57 | 103 | 3 | 1179 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 4.23e-03 | 115 | 103 | 4 | 769 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 4.63e-03 | 18 | 103 | 2 | 620 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.63e-03 | 18 | 103 | 2 | 91 | |
| GeneFamily | FKBP prolyl isomerases | 4.63e-03 | 18 | 103 | 2 | 910 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 5.16e-03 | 19 | 103 | 2 | 50 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.34e-03 | 66 | 103 | 3 | 722 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | EPHB3 RELN ZNF609 TCF12 NAPEPLD CLASP1 CAMK2A OTUD1 GOSR1 LCA5L CHGB ZNF365 SORCS1 CCDC88C RNASEL SATB1 CCNE2 AUTS2 SLC39A6 GPSM2 CEP295 EIF3A ZC3H12C DMD PARPBP CDH4 | 4.58e-06 | 1370 | 152 | 26 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-07 | 184 | 157 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-07 | 184 | 157 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-07 | 184 | 157 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Trm_Tgd|Liver / Manually curated celltypes from each tissue | 1.27e-06 | 154 | 157 | 7 | c6308074468235c88ef4ea43ab155d9f86cbf261 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.88e-06 | 104 | 157 | 6 | b5ca6e589f414e549f4990fe334d4ee54829b298 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-06 | 167 | 157 | 7 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | pdx-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.12e-06 | 190 | 157 | 7 | b05db0de9b6ae01dd30074453f7de44f7397631e | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 6.28e-06 | 196 | 157 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.71e-06 | 198 | 157 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.16e-05 | 159 | 157 | 6 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 2.48e-05 | 163 | 157 | 6 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 164 | 157 | 6 | 1d0d88132baaa3154c3e6e4ef0aff795afab08a2 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 164 | 157 | 6 | bd2e10b015d5e6a338675500ec5d81dc39583b3e | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_C|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.94e-05 | 168 | 157 | 6 | 0372c06b70f0ba95bf8cd1363ca7c5f31207f094 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-05 | 170 | 157 | 6 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.24e-05 | 171 | 157 | 6 | 121e63ca281ad765d76c2afb3b4d441329b47f81 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.93e-05 | 177 | 157 | 6 | 59cf56c385c324f0844f20003d2b5049a2791e45 | |
| ToppCell | wk_15-18-Epithelial-PNS-COL20A1+_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.93e-05 | 177 | 157 | 6 | b8cc6a7abf83a9844a5293b6cc4b19135b51fd53 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-05 | 179 | 157 | 6 | 7ae67e1c09a4ce9b3bcec4c48ee9cf2b1cb4e339 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-05 | 180 | 157 | 6 | d9c9399df3e2d9f23dbbfffb6cbe8404bf01e2b7 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-05 | 180 | 157 | 6 | dad458398683ff80a6e207bdc08e257d1bb757d6 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.60e-05 | 182 | 157 | 6 | 1923932a9c60e9ec33db69ded441210d1fb07bec | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.60e-05 | 182 | 157 | 6 | 69ff652f74cc47fbe0bd665ab17c445c5b959dad | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.88e-05 | 184 | 157 | 6 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-05 | 185 | 157 | 6 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.19e-05 | 186 | 157 | 6 | cf96f880e6e22189593ce1357c55e65c34644559 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.19e-05 | 186 | 157 | 6 | c984e5729958237b101df96d1c89a236faacded6 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 5.19e-05 | 186 | 157 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-05 | 187 | 157 | 6 | 16e55d802fc4e71878305e61ad03806aabd59537 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.67e-05 | 189 | 157 | 6 | bed43041e6f8ba19787150a6aaa492f2656135d9 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.67e-05 | 189 | 157 | 6 | 0739baad9a7da511dd3d7249f84299aee88370a1 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_postreplicative-neuro_immature_neuronal_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.67e-05 | 189 | 157 | 6 | de06ef69f3f97b3f21dc269eb6965da9b2f6e3f8 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.67e-05 | 189 | 157 | 6 | ce5b3d53c9a5457a5a02b221dee18334b5eaf8b7 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-05 | 190 | 157 | 6 | e2481bd5166fde2cdc0c3824894f2bccb8294fdd | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-05 | 191 | 157 | 6 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 6.18e-05 | 192 | 157 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-Secretory/RAS-RAS|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.36e-05 | 193 | 157 | 6 | 525e0de0f25f3308daf49e7d4c8774562f1f40ad | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-Secretory/RAS|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.36e-05 | 193 | 157 | 6 | 2d18f39615043dfbff120a00f6540ffa93082c83 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-05 | 195 | 157 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.74e-05 | 195 | 157 | 6 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-05 | 195 | 157 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-NK|COVID-19_Severe / Disease group, lineage and cell class | 6.93e-05 | 196 | 157 | 6 | cc1daf12de5765ba4f7002396352404b41df2012 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.93e-05 | 196 | 157 | 6 | d3bd8fab010e76024d7e06aba0ea5df3394f411f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.93e-05 | 196 | 157 | 6 | 77da6b1bcab45d376eb0368f540e0ed24ce98b42 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.93e-05 | 196 | 157 | 6 | 17f17edadafdad9f24e88d708d7e1c765503131c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.96e-05 | 121 | 157 | 5 | 7f2057367777c6c92f596054cbc5fe567d079fbc | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.13e-05 | 197 | 157 | 6 | 9993fdea353abeafc009ac87439ad25cedf8f1f6 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.13e-05 | 197 | 157 | 6 | 300849a922722adcbc068593fc5cc0bef936d9cb | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.13e-05 | 197 | 157 | 6 | a8b41fffa4e86f2766423392951ff320e821a19a | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.13e-05 | 197 | 157 | 6 | a97c4a9eb89260b0b5745834ccef9d558d857f93 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.33e-05 | 198 | 157 | 6 | 22935a8afac54021f68b5f7a5accf51523e2f336 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.53e-05 | 199 | 157 | 6 | dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.53e-05 | 199 | 157 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.53e-05 | 199 | 157 | 6 | c1760581c34b81d1d92c67500a1c8944e9cc6dad | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK|COVID-19_Severe / Disease, condition lineage and cell class | 7.75e-05 | 200 | 157 | 6 | 2580b7b83ba707718fe23ffca986e7a55ea85bce | |
| ToppCell | Globus_pallidus|World / BrainAtlas - Mouse McCarroll V32 | 8.44e-05 | 126 | 157 | 5 | 44b63f945d5bedf1a2ca1810e7e100276ea9dd89 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Ptrf|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.09e-04 | 133 | 157 | 5 | a1bc34e5dda4ff4716b857931cc196f6770f58f4 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.17e-04 | 135 | 157 | 5 | c7c30b993b3ddac8f1677d5fe47dc2e66d0d26ac | |
| Drug | cyclopentanol | 3.03e-07 | 3 | 154 | 3 | ctd:C016327 | |
| Drug | cyclopentanone | 3.03e-07 | 3 | 154 | 3 | ctd:C007201 | |
| Drug | 4-benzoylbenzoic acid | 3.03e-07 | 3 | 154 | 3 | ctd:C058818 | |
| Drug | dichloro(4-cymene)ruthenium(II) | 3.03e-07 | 3 | 154 | 3 | ctd:C530610 | |
| Drug | Etidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; PC3; HT_HG-U133A | DISC1 ASH1L VPS13D SMG7 NFATC3 ZNF197 AKAP13 PLD1 ARHGEF4 ZNF222 | 1.07e-06 | 199 | 154 | 10 | 4564_DN |
| Drug | cloxazolam | 1.21e-06 | 4 | 154 | 3 | ctd:C005522 | |
| Drug | Pregnanes | 1.21e-06 | 4 | 154 | 3 | ctd:D011278 | |
| Drug | tetralol | 1.21e-06 | 4 | 154 | 3 | ctd:C019106 | |
| Drug | gliquidone | 1.21e-06 | 4 | 154 | 3 | ctd:C010969 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 1.21e-06 | 4 | 154 | 3 | ctd:C018156 | |
| Drug | PK-F | 1.91e-06 | 14 | 154 | 4 | CID000448133 | |
| Drug | Hydroxysteroids | 3.00e-06 | 5 | 154 | 3 | ctd:D006914 | |
| Drug | NSC86000 | 3.00e-06 | 5 | 154 | 3 | CID000257630 | |
| Drug | cresolphthalein | 3.00e-06 | 5 | 154 | 3 | ctd:C010092 | |
| Drug | Estazolam | 5.98e-06 | 6 | 154 | 3 | ctd:D004949 | |
| Drug | Glipizide | 5.98e-06 | 6 | 154 | 3 | ctd:D005913 | |
| Drug | acenaphthene-1-ol | 5.98e-06 | 6 | 154 | 3 | ctd:C023723 | |
| Drug | Medazepam | 5.98e-06 | 6 | 154 | 3 | ctd:D008472 | |
| Drug | 4-hydroxyequilenin-o-quinone | 1.04e-05 | 7 | 154 | 3 | ctd:C117714 | |
| Drug | zomepirac | 1.04e-05 | 7 | 154 | 3 | ctd:C020549 | |
| Drug | Flunitrazepam | 1.10e-05 | 21 | 154 | 4 | ctd:D005445 | |
| Drug | Nitrazepam | 1.66e-05 | 8 | 154 | 3 | ctd:D009567 | |
| Drug | medazepam | 1.92e-05 | 24 | 154 | 4 | CID000004041 | |
| Drug | 4-hydroxybenzoic acid | 2.47e-05 | 9 | 154 | 3 | ctd:C038193 | |
| Drug | 20-alpha-Dihydroprogesterone | 2.47e-05 | 9 | 154 | 3 | ctd:D004092 | |
| Drug | 4-oxo-2-nonenal | 2.47e-05 | 9 | 154 | 3 | ctd:C403894 | |
| Drug | octyl gallate | 3.52e-05 | 10 | 154 | 3 | ctd:C016627 | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A | 3.59e-05 | 183 | 154 | 8 | 6874_UP | |
| Drug | alpha-methylcinnamic acid | 4.55e-05 | 2 | 154 | 2 | ctd:C510582 | |
| Drug | 2-Phosphoglycolic Acid | 4.55e-05 | 2 | 154 | 2 | DB02726 | |
| Drug | N-methyltaurine | 4.55e-05 | 2 | 154 | 2 | CID000007882 | |
| Drug | NPCMD | 4.55e-05 | 2 | 154 | 2 | CID000126341 | |
| Drug | BW A440C | 4.55e-05 | 2 | 154 | 2 | CID003086296 | |
| Drug | 3-(fluoromethyl)phosphoenolpyruvate | 4.55e-05 | 2 | 154 | 2 | CID006443899 | |
| Drug | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | 4.55e-05 | 2 | 154 | 2 | DB07768 | |
| Drug | SENP | 4.55e-05 | 2 | 154 | 2 | CID003082911 | |
| Drug | 8-BDB-TATP | 4.55e-05 | 2 | 154 | 2 | CID003082732 | |
| Drug | AC1Q6SAF | 4.55e-05 | 2 | 154 | 2 | CID000194977 | |
| Drug | Adenosine 5'-monophosphate 1-oxide | 4.55e-05 | 2 | 154 | 2 | CID000492161 | |
| Drug | baccharin | 4.55e-05 | 2 | 154 | 2 | ctd:C012764 | |
| Drug | phenolphthalein | 4.55e-05 | 58 | 154 | 5 | CID000004764 | |
| Drug | Dihydroxydihydrobenzopyrenes | 4.81e-05 | 11 | 154 | 3 | ctd:D004101 | |
| Drug | 7-hydroxyflavone | 4.81e-05 | 11 | 154 | 3 | ctd:C429845 | |
| Drug | chlordecone alcohol | 4.81e-05 | 11 | 154 | 3 | CID000013946 | |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 5.43e-05 | 194 | 154 | 8 | 4961_UP | |
| Drug | 5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA | 5.63e-05 | 195 | 154 | 8 | 834_UP | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Down 200; 14uM; PC3; HT_HG-U133A | 6.05e-05 | 197 | 154 | 8 | 6623_DN | |
| Drug | Iocetamic acid [16034-77-8]; Up 200; 6.6uM; HL60; HT_HG-U133A | 6.27e-05 | 198 | 154 | 8 | 3022_UP | |
| Drug | Oxytetracycline dihydrate [6153-64-6]; Down 200; 8uM; HL60; HG-U133A | 6.27e-05 | 198 | 154 | 8 | 1553_DN | |
| Drug | fenamic acid | 6.38e-05 | 12 | 154 | 3 | ctd:C001209 | |
| Drug | Phenolphthalein | 6.38e-05 | 12 | 154 | 3 | ctd:D020113 | |
| Drug | DMBA-3,4-dihydrodiol | 8.26e-05 | 13 | 154 | 3 | CID000050096 | |
| Drug | flunisolide | 8.26e-05 | 13 | 154 | 3 | ctd:C007734 | |
| Drug | AC1LADSU | 8.26e-05 | 13 | 154 | 3 | CID000486173 | |
| Drug | Nitrogen oxides | 8.95e-05 | 35 | 154 | 4 | CID000160954 | |
| Drug | estazolam | 8.95e-05 | 35 | 154 | 4 | CID000003261 | |
| Drug | Dydrogesterone | 1.05e-04 | 14 | 154 | 3 | ctd:D004394 | |
| Drug | 5-alpha-Dihydroprogesterone | 1.05e-04 | 14 | 154 | 3 | ctd:D043582 | |
| Drug | 1-acenaphthenol | 1.05e-04 | 14 | 154 | 3 | CID000022750 | |
| Drug | Meclofenamic Acid | 1.05e-04 | 14 | 154 | 3 | ctd:D008469 | |
| Drug | diethoxyfluorescein | 1.36e-04 | 3 | 154 | 2 | CID000161373 | |
| Drug | NSC 18508 | 1.36e-04 | 3 | 154 | 2 | CID000189182 | |
| Drug | 1-thio-alpha-tocopherol | 1.36e-04 | 3 | 154 | 2 | CID000131683 | |
| Drug | 5-dihydrodeoxycorticosterone | 1.36e-04 | 3 | 154 | 2 | ctd:C454687 | |
| Drug | 2 PEB | 1.36e-04 | 3 | 154 | 2 | CID000447809 | |
| Drug | Mefenamic Acid | 1.38e-04 | 39 | 154 | 4 | ctd:D008528 | |
| Drug | Salicylic Acid | 1.38e-04 | 39 | 154 | 4 | ctd:D020156 | |
| Drug | AC1NUW4G | 1.52e-04 | 40 | 154 | 4 | CID005462134 | |
| Drug | AC1MHEDL | 1.88e-04 | 78 | 154 | 5 | CID003002890 | |
| Drug | benzo(a)pyrene-1,6-quinone | 1.92e-04 | 17 | 154 | 3 | ctd:C030233 | |
| Drug | androsterone glucuronide | 2.02e-04 | 43 | 154 | 4 | CID000114833 | |
| Disease | Neoplasms, Hormone-Dependent | 1.14e-07 | 3 | 144 | 3 | C0027661 | |
| Disease | Hermaphroditism | 1.13e-06 | 5 | 144 | 3 | C0019269 | |
| Disease | Ambiguous Genitalia | 1.13e-06 | 5 | 144 | 3 | C0266362 | |
| Disease | Pseudohermaphroditism | 1.13e-06 | 5 | 144 | 3 | C0033804 | |
| Disease | Intersex Conditions | 1.13e-06 | 5 | 144 | 3 | C2930618 | |
| Disease | Sex Differentiation Disorders | 1.13e-06 | 5 | 144 | 3 | C2930619 | |
| Disease | Disorders of Sex Development | 3.93e-06 | 7 | 144 | 3 | C0036875 | |
| Disease | Major Depressive Disorder | 1.99e-04 | 243 | 144 | 7 | C1269683 | |
| Disease | Mental Depression | 2.60e-04 | 254 | 144 | 7 | C0011570 | |
| Disease | Unipolar Depression | 2.93e-04 | 259 | 144 | 7 | C0041696 | |
| Disease | schizophrenia (implicated_via_orthology) | 3.48e-04 | 68 | 144 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | cortolone glucuronide (1) measurement | 3.50e-04 | 6 | 144 | 2 | EFO_0800552 | |
| Disease | Schizophrenia | RELN ADAMTS3 DISC1 ADNP2 ETNPPL CHGB CSMD2 BRAP SLC6A2 UGT1A3 AUTS2 HTR3B CSMD1 | 4.05e-04 | 883 | 144 | 13 | C0036341 |
| Disease | Depressive disorder | 5.64e-04 | 289 | 144 | 7 | C0011581 | |
| Disease | Cardiomegaly | 7.08e-04 | 82 | 144 | 4 | C0018800 | |
| Disease | Cardiac Hypertrophy | 7.08e-04 | 82 | 144 | 4 | C1383860 | |
| Disease | Sclerocystic Ovaries | 7.21e-04 | 144 | 144 | 5 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 7.21e-04 | 144 | 144 | 5 | C0032460 | |
| Disease | macrophage colony stimulating factor measurement | 7.83e-04 | 37 | 144 | 3 | EFO_0008217 | |
| Disease | HVA measurement, MHPG measurement | 9.85e-04 | 40 | 144 | 3 | EFO_0005131, EFO_0005133 | |
| Disease | hydroxyproline measurement | 1.04e-03 | 10 | 144 | 2 | EFO_0010498 | |
| Disease | B-lymphoblastic leukemia/lymphoma (is_implicated_in) | 1.04e-03 | 10 | 144 | 2 | DOID:0080630 (is_implicated_in) | |
| Disease | temporomandibular joint disorder | 1.04e-03 | 10 | 144 | 2 | EFO_0005279 | |
| Disease | complement factor H-related protein 3 measurement | 1.47e-03 | 169 | 144 | 5 | EFO_0600056 | |
| Disease | Bell's palsy | 1.60e-03 | 102 | 144 | 4 | EFO_0007167 | |
| Disease | Pain, Migratory | 1.78e-03 | 49 | 144 | 3 | C0751407 | |
| Disease | Suffering, Physical | 1.78e-03 | 49 | 144 | 3 | C0751408 | |
| Disease | Pain, Crushing | 1.78e-03 | 49 | 144 | 3 | C0458259 | |
| Disease | Pain, Splitting | 1.78e-03 | 49 | 144 | 3 | C0458257 | |
| Disease | fetal genotype effect measurement, body weights and measures | 1.78e-03 | 49 | 144 | 3 | EFO_0004324, EFO_0007959 | |
| Disease | Pain | 1.78e-03 | 49 | 144 | 3 | C0030193 | |
| Disease | Radiating pain | 1.78e-03 | 49 | 144 | 3 | C0234254 | |
| Disease | Pain, Burning | 1.78e-03 | 49 | 144 | 3 | C0234230 | |
| Disease | Ache | 1.78e-03 | 49 | 144 | 3 | C0234238 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.78e-03 | 49 | 144 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | blood copper measurement | 1.89e-03 | 50 | 144 | 3 | EFO_0007578 | |
| Disease | pneumonia, COVID-19 | 2.32e-03 | 113 | 144 | 4 | EFO_0003106, MONDO_0100096 | |
| Disease | essential hypertension, age at diagnosis | 2.61e-03 | 56 | 144 | 3 | EFO_0004918, MONDO_0001134 | |
| Disease | response to methotrexate | 2.71e-03 | 16 | 144 | 2 | GO_0031427 | |
| Disease | neuropsychological test | 2.87e-03 | 197 | 144 | 5 | EFO_0003926 | |
| Disease | sugar consumption measurement | 2.88e-03 | 120 | 144 | 4 | EFO_0010158 | |
| Disease | pyroglutamine measurement | 2.89e-03 | 58 | 144 | 3 | EFO_0005408 | |
| Disease | caudal middle frontal gyrus volume measurement | 3.44e-03 | 18 | 144 | 2 | EFO_0010290 | |
| Disease | memory performance | 4.05e-03 | 409 | 144 | 7 | EFO_0004874 | |
| Disease | alkaline phosphatase measurement | ADAMTS2 NRTN ATP13A1 ERGIC2 TXNDC11 PPL TRANK1 PMPCA NFATC3 CLPTM1 AKAP13 CHPF2 | 4.20e-03 | 1015 | 144 | 12 | EFO_0004533 |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 4.24e-03 | 216 | 144 | 5 | EFO_0007925, EFO_0007927 | |
| Disease | Precursor B-cell lymphoblastic leukemia | 4.67e-03 | 21 | 144 | 2 | C1292769 | |
| Disease | disease of metabolism (implicated_via_orthology) | 4.67e-03 | 21 | 144 | 2 | DOID:0014667 (implicated_via_orthology) | |
| Disease | Liver Cirrhosis, Experimental | A2M APMAP TOR4A AKR1C1 NCOR2 RNASEL PTRHD1 PKLR AKR1C3 SLC39A6 | 4.80e-03 | 774 | 144 | 10 | C0023893 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RHVLGHTQLYFETEH | 91 | P35503 | |
| LLDRAHSDYDSVFHH | 466 | Q9H2F5 | |
| VSRHAYKHFEETQHT | 341 | Q7Z569 | |
| YSERDFEFHRHTSHH | 66 | P48751 | |
| LEGRASHSDHEFLFH | 411 | Q5FYA8 | |
| HETHHSPSRRFYHNE | 2726 | Q9NR48 | |
| YYEVLEHTSDILRHH | 246 | Q9NZN9 | |
| LHDEEATIIHHYAFS | 161 | Q6Y288 | |
| IFHTFHLESSHDYLL | 971 | Q96PZ7 | |
| FHTFHLESGHDYLLI | 966 | Q7Z408 | |
| TFHLEDHHDYLLITE | 1111 | Q7Z407 | |
| AIEAGFRHIDSAHLY | 41 | P42330 | |
| ATDTHHPQDSALYHL | 21 | O95264 | |
| YHHIHTEISREGARV | 671 | Q9HD20 | |
| VNHESYNFSHRIDHL | 206 | Q96RQ1 | |
| DIYTLTSESDSHHEH | 251 | Q12802 | |
| EEDLYDDLHSSSHHY | 161 | Q9NR80 | |
| ESRYVHDKHFEVLHS | 121 | O96020 | |
| RLTHFAHAARDHETT | 941 | Q8IYW2 | |
| VHEHDGHLYLGSFRS | 391 | Q9HDC9 | |
| DSTGHDALHYALHTQ | 216 | Q8N283 | |
| PQLSHDDTHSRIEHY | 3426 | P11532 | |
| DDTHSRIEHYASRLA | 3431 | P11532 | |
| DHLEFAEDDLSHYTR | 216 | P16066 | |
| SVEDHIEYHGHRGSA | 281 | Q8WUJ3 | |
| YLEDQLHTAIHSHDE | 791 | Q9NRI5 | |
| FRGHQDVITLDHAYH | 126 | Q8TBG4 | |
| DVITLDHAYHGHLSS | 131 | Q8TBG4 | |
| DHAYHGHLSSLIEIS | 136 | Q8TBG4 | |
| HDEYHDHAIFLTRQD | 356 | O95450 | |
| HEEAHHTAYLVFSPS | 441 | P01023 | |
| FHYRTLHSDDEGTVL | 36 | O00170 | |
| TSFKNHLHRYHEDEI | 86 | Q6IQ32 | |
| LYHPNSFTHHERAIT | 181 | Q8N123 | |
| SSHRHPHVVYLDDRE | 1016 | A6NNM3 | |
| SSHRHPHVVYLDDRE | 1016 | A6NJZ7 | |
| LYDEENTIHHHGTSI | 376 | Q9NWS1 | |
| ATHGRHVQYLDFLHT | 1291 | Q14573 | |
| EYRRSPTHLNHDHDI | 111 | Q9UKR3 | |
| EDEVSFLDAHSRYHT | 171 | Q99748 | |
| FLDAHSRYHTVHELS | 176 | Q99748 | |
| EAGYTIFHHAALHNR | 531 | Q7Z5J8 | |
| ARTHTDVGLLEYQHH | 31 | Q9Y618 | |
| EQTVHYIADHLDHFS | 341 | Q5VV17 | |
| HRDILQDYTHEFHKT | 111 | O95249 | |
| ALEYHHHDLTLARTI | 81 | P81274 | |
| IHHLDHRYLELESSG | 106 | Q99435 | |
| HYAHTHLASEEGDEA | 216 | Q92784 | |
| GETHIDLENRFYSHH | 1331 | A9Z1Z3 | |
| HEHLGTLHERQSAEY | 1171 | Q9P219 | |
| QSAKAAYEHFHRGHD | 726 | O60437 | |
| EHHHLAVAYSSGRLD | 786 | Q5VY43 | |
| GFDHHATHILQFDRY | 986 | Q6ZNL6 | |
| HYSDHLNDSRLGAHE | 81 | Q99081 | |
| RLSHPHHYSSDREND | 141 | Q8WXX7 | |
| DYEHTRLHSVHPASL | 1161 | Q8WXX7 | |
| SHITHLFENDRHFSH | 36 | Q2PZI1 | |
| YHEGLSDHIQEELSH | 206 | Q86TG7 | |
| AHYSHRALDDDIRHQ | 261 | Q8IVB5 | |
| HISHLLAHTRYTFEV | 411 | P54753 | |
| RRHYSFTEATENLHH | 521 | O95447 | |
| VARLNFSHGTHEYHA | 71 | P14618 | |
| FSHGTHEYHAETIKN | 76 | P14618 | |
| RLNFSHGSHEYHAES | 116 | P30613 | |
| HGSHEYHAESIANVR | 121 | P30613 | |
| AHGLETDIHLSYDHV | 226 | Q6W3E5 | |
| HSDSIILRDDFDSYH | 196 | P78509 | |
| EHFLLHREGTFNHTL | 56 | Q14953 | |
| AREYAVSSHHHVICE | 341 | A0JP26 | |
| VSSHHHVICELLSDY | 346 | A0JP26 | |
| HDTTRPEEFDHYVHF | 186 | P51582 | |
| SFDIYHLSREGEAHE | 151 | Q99706 | |
| HGHHESRAYRALTET | 336 | P10696 | |
| EGSSLYHHLHVADTR | 386 | P10398 | |
| HSEHHDHAIFLTRQD | 346 | O15072 | |
| FHASTLHRLYHLSRE | 291 | Q14152 | |
| YDRGAEAKSVFHHSH | 986 | Q7Z3S7 | |
| LRSLDADSFHYHTLE | 616 | Q9H6X5 | |
| DHADFHHSVKSPELY | 381 | Q8TAL5 | |
| DGCYHLETSTHHFLS | 186 | Q9NQT6 | |
| DRDDHVEVLSPSHHY | 566 | P57058 | |
| DREEHASYHLRAHAV | 236 | P55283 | |
| SDIAVRLLHTHYDHV | 246 | Q6TDU7 | |
| HHSTVADGLITTLHY | 201 | P00519 | |
| ILSSHDIEQHAPYRH | 476 | O75426 | |
| HLSVEELKRHYESTH | 1431 | Q9Y4F3 | |
| TEYRIDIHACNHAAH | 781 | P14616 | |
| ATYLEHHVAEHTAES | 286 | Q92636 | |
| DEHHSTLVSTRHYRA | 331 | Q9HAZ1 | |
| YRDSHTDSHLHTRQH | 61 | P48728 | |
| LTASDRALHDHCYVH | 831 | Q9NYQ7 | |
| STYHHLHTFVNRETD | 191 | Q9C0D2 | |
| LEEHYRFHEFHSPAL | 36 | Q9H4M9 | |
| DHHSTHYRASEEEPE | 326 | P05060 | |
| VAEHHDRVHLRSTYH | 891 | Q96RY7 | |
| LSYNHHRLEEHEAET | 301 | Q9H756 | |
| HNKHELAHAFDRYET | 121 | Q96AX9 | |
| AREYAVSSHHHVICE | 341 | B2RU33 | |
| VSSHHHVICELLSDY | 346 | B2RU33 | |
| HEVVYFSAAHALREH | 576 | Q9UBD5 | |
| AREYAVSSHHHVICE | 341 | Q86YR6 | |
| VSSHHHVICELLSDY | 346 | Q86YR6 | |
| HVHSFSYDFHLRLVH | 3041 | Q5T011 | |
| HHSYEDTGLLCIHAS | 381 | Q10713 | |
| AEFYERGVLHLHESS | 211 | P23975 | |
| HHINLSTVTAEDYHL | 391 | Q9H2J7 | |
| THRDHPHTAAYLQEL | 61 | Q6GMV3 | |
| SIHAAYVHVIENSRH | 761 | Q13393 | |
| SSHRHPHVVYLDDRE | 1016 | Q9UFD9 | |
| HHLRDFSNETEQHTY | 306 | Q92540 | |
| ETHAHYIDVARLLHA | 2921 | Q96Q15 | |
| HLVTFYGSESHRGHL | 416 | Q05823 | |
| HTGNFRDLYHILENH | 141 | O95343 | |
| HDSISEEGHHYLIFD | 76 | Q9UQM7 | |
| LEEHYRFHEFHSPAL | 36 | Q9NZN3 | |
| LAYEEHHAHRVLTHF | 51 | Q8IYS1 | |
| DMHGYDIRRFHHSLT | 436 | Q9UL12 | |
| IYEQESNAVHHHGDR | 566 | Q01826 | |
| THLSLTAIEYSHSHD | 471 | Q96GD3 | |
| HSHFHDTLGQSDDLI | 541 | Q13433 | |
| HSGEDYSRDEDHIAH | 466 | Q9UPE1 | |
| YFHQDDIGHLAECHR | 376 | O00327 | |
| AIEAGFRHIDSAHLY | 41 | Q04828 | |
| AIEAGFHHIDSAHVY | 41 | P52895 | |
| HVYISEHEHFTDFNA | 106 | O96005 | |
| SETLRHLHTHFGADY | 161 | Q9P2E5 | |
| DFITHLYAGADVHRH | 66 | Q13057 | |
| HFSREAEHLYHTLES | 516 | Q7Z460 | |
| DLRLEHTHFFSRHGE | 261 | Q9H0W9 | |
| HIDSHAEEREDHEYY | 361 | Q6S5L8 | |
| HIVRFSHHFEDADNI | 121 | Q9H4B4 | |
| NLHLYLTHERTHTGE | 21 | Q6ZTB9 | |
| LESGHYTSFIRHHKD | 376 | A6NNY8 | |
| SHLHFRQLRYHETSG | 41 | O14709 | |
| HSSYLRIHERVHTGE | 626 | Q8N8Z8 | |
| SSLRAHLEFSHSYEE | 41 | Q70YC5 | |
| GQLYHHEAQHFRDAS | 786 | Q13129 | |
| SHSVGRYAFLEHDIV | 96 | Q9UHP6 | |
| LDQHLGDHSSESHFL | 351 | Q6ZN55 | |
| HFRSFHYHEATEPLE | 51 | Q92670 | |
| HGSSYRLHLRVHHDD | 586 | Q5SVQ8 | |
| RHATSLIYHDRTHAG | 571 | Q96SK3 | |
| DSSYLLRHQRTHSHE | 356 | Q9H5H4 | |
| GLKYHQAHAHTDDDS | 511 | O15014 | |
| THHRAHYETEGSRGA | 441 | Q12968 | |
| DHRDYSLTCRNHALH | 271 | O95685 | |
| YHCQLIEHSRIHTGD | 456 | O75290 | |
| EVSASEHGAQHHIYR | 416 | Q15561 | |
| HTSEFNYHRRIHTGE | 616 | O15060 | |
| VSLVHSGSVYLHRHF | 311 | Q6PKC3 | |
| EDSALVLQYHARHHC | 216 | Q9NXH8 | |
| HTSYLLEHQRVHHEE | 341 | Q8N720 | |
| YNSHLASHRRVHTGE | 471 | Q09FC8 | |
| AFIHSSSLRYHERIH | 396 | Q9UC07 | |
| RHSYLAEHQTVHTGE | 336 | Q3MIS6 | |
| FAQIAGAVRYLHDHH | 116 | Q9BXA6 | |
| YLHSEDLFDILHNTH | 301 | Q6R2W3 | |
| SHYDGIRSLAFHHSQ | 436 | Q9NRL3 | |
| ASGRHEHHDVAEQYF | 281 | Q5W5X9 | |
| DHLGHDLGHLYVEST | 36 | Q9C0D7 | |
| SESYEQHIHLEHHQR | 2771 | O15050 | |
| LVHLEARTVDGHSHY | 331 | Q8WY21 | |
| SHEDLRFHVNSHEAG | 476 | Q9H4Z2 | |
| HSLVHLNEVESGYHS | 81 | O94900 | |
| DHRFESVSHLISYHM | 546 | P29353 | |
| LDFHHRTHTGERSYN | 356 | Q9UK12 | |
| VSRLLLHPYHEEDSH | 651 | Q8IU80 | |
| HHSNEVGAAAETHLY | 411 | Q9P2D8 | |
| EEAHFTRHDFFESLH | 1466 | Q5THJ4 | |
| VLISHNHYDHLDYNS | 181 | Q6IQ20 |